CMS Includes Endoscopic Spine in Fee Schedule Proposed Rule for CY 2017

Baltimore, MD – July 14, 2016– The Centers for Medicare & Medicaid Services (CMS) recently released the proposed rules for the 2017 Medicare Physician Fee Schedule (MPFS) and the 2017 Hospital Outpatient Prospective Payment System (HOPPS). Both proposed rules provide information on physician and hospital payment for the newly created CPT code 630X1 for endoscopic decompression of the lumbar spine.

“This is a great step towards the acceptance of endoscopic minimally invasive spine surgery techniques and their benefits to both the surgeon and their patients in the U.S.,” said Wolfgang Ries, Founder and CEO of joimax®. This announcement is in alignment with the reimbursement decision of NICE, UK, in April of 2016, to fully reimburse endoscopic procedures.

A key reason for the recent momentum for endoscopic, minimally invasive spinal surgery is the significant, favorable base of literature, which validates evidence of the efficacy of endoscopic minimally invasive spine surgery. A special edition, “Neurosurgical Focus”, published by the Journal of Neurosurgery (JNS) in February 2016, contains a range of studies on endoscopic spine surgery.

joimax® hosts symposium at WCMISST; presents Kambin Award to German Surgeons

Karlsruhe, Germany – June 9, 2016 – joimax®, the global developer and marketer of technologies and treatment methods for minimally invasive endoscopic spinal surgery, recently hosted an educational symposium and exhibit during the 5th World Congress of Minimally Invasive Spine Surgery & Techniques (WCMISST), held June 1-4, in Jeju Island, Korea. The World Congress, which takes place every two years, is attended by more than 500 physicians and is recognized as one of the most important congresses for minimally invasive spine surgery.

Additionally, joimax® hosted an educational symposium for spine surgeons from across the globe. ”About 200 attendees gathered to learn about the techniques of endoscopic minimally invasive spine surgery and the benefits of these techniques to both the surgeon and their patients,” said Wolfgang Ries, founder and CEO of joimax®. During the Congress’ Gala Dinner, joimax® had the honour of presenting the Parviz Kambin Award to Dr. Guntram Krzok and Dr. Ralf Wagner, both from Germany, for their excellence in endoscopic spinal surgery. The Parviz Kambin Award is presented to pioneers in the field of endoscopic minimally invasive spine surgery. Nominees are selected by SMISS, WCMISST and joimax®.

Dr. Guntram Krzok, owner of a private practice in Friedrichsroda, Germany, has performed more than 3,000 endoscopic and transforaminal surgeries since 1999 and has provided training at 100 workshops. He was the first surgeon to introduce the TESSYS® technique in China and routinely publishes about his growing experience in the field.

Since 2007, Dr. Ralf Wagner, from the Ligamenta Spine Center in Frankfurt, has performed nearly 2,700 endoscopic surgeries with transforaminal, interlaminar and cervical systems, as well as endoscopic assisted stabilization with the joimax® EndoLIF® technique. He, too, has provided training at nearly 100 workshops, is an active speaker at international congresses and has published numerous scientific articles.

The Kambin Award, named after Dr. Parviz Kambin, was originally presented to Dr. Kambin (Philadelphia, PA) by the Society for Minimally Invasive Spine Surgery (SMISS) and joimax® at meeting held in April of 2011 in Denver, CO. Previous award recipients include: Dr. Michael Schubert (Munich, Germany), Dr. Menno Iprenburg (Veenhuizen, the Netherlands), Dr. Anthony Yeung (Phoenix, AZ), Dr. Florian Maria Alfen (Würzburg, Germany), Dr. Daniel Laich (Chicago, IL), Dr. Gabriele Jasper (Brick, NJ), Dr. Albert Telfeian (Providence, RI) and Dr. Sang-Ho Lee (Seoul, Korea).

joimax® hosts SpineWeek symposium, leads live surgery broadcast during CAOS-NASS

Karlsruhe, Germany and Singapore, Chengdu/Shanghai, China (May 25, 2016) – joimax®, the global developer and marketer of technologies and treatment methods for minimally invasive endoscopic spinal surgery, recently hosted an educational symposium and exhibited at SpineWeek in Singapore. SpineWeek takes place every four years and is viewed as one of the most important congresses, representing numerous international society leaders.

“The decision to participate in this congress was the right step to demonstrate our presence in the Asian region,” says Wolfgang Ries, CEO and founder of joimax®. “This year, there was a clear focus on endoscopic treatments by the participating societies, which created a strong interest in our lunch symposium. Approximately 200 attendees gathered to learn about the techniques of endoscopic minimally invasive spine surgery and the benefits of these techniques to both the surgeon and their patients,” continued Ries.

To further validate the company’s expansion and presence in China, joimax® participated in the 9th Congress of the Chinese Association of Orthopaedic Surgeons – North American Spine Society (CAOS/NASS) meeting in Chengdu, China. The company was also involved with the Master Techniques in Spine Surgery Workshop, held on May 20, 2016 in Shanghai, China. Dr. Ralf Wagner, of the Ligamenta Spine Center in Frankfurt, Germany, led the technique-focused workshop and surgery, which was broadcast live to the meeting in Chengdu, as well as online to 30,000 Chinese surgeons.

joimax® turns 15 years

Karlsruhe, Germany and Chicago, Illinois (April 30, 2016) – joimax®, the global acting German developer and marketer of technologies and treatment methods for minimally invasive endoscopic spinal surgery, is celebrating its 15th anniversary worldwide in 2016 starting at AANS in Chicago combined with a joimax® Senior Faculty Meeting. The aim of this meeting is to share experience, deepen expertise, specifically in reference to the newest joimax® products and applications as well as to refine the specific surgical techniques. Key topics will be centered around endoscopic treatment of degenerative spine diseases.

“When I started with the TESSYS® system in 2006 I was wondering at which patient indications this system could be applied”, says Daniel Laich, DO at Swedish Covenant Hospital in Chicago, Il.
“Now we are doing all kind of special stenotic cases and even thoracic disc, or even tumor treatments”, continues Albert Telfeian, MD, PhD at the Hasbro Hospital of The Warren Alpert Medical School at Brown University, Rhode Island.
“With the iLESSYS® Delta System I can even do an over-the-top decompression in a central stenotic patient and with the EndoLIF® method I do an endoscopic assisted stabilization if indicated” finishes Ralf Wagner, MD from the Ligamenta Spine Center in Frankfurt, Germany.

joimax®, entirely focused on treatment technologies for endoscopic minimally-invasive spinal surgery, over the years launched more than 10 different indication driven systems providing a company growth rate of over 35% per annum. To date more than 180.000 patients had been treated in over 40 countries with the various methods, based on more than 140 patents and trademarks issued globally. “The major company growth and market evolutional steps are further out in front of the companies’ future, based on solid ground with broad market adoption starting just now”, states Wolfgang Ries, CEO and founder of joimax®.